Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

Filgotinib is an effective and well-tolerated treatment option for UC, including DTT disease. No new safety signals were found.

Authors

Institutions

Publication Details

Journal
United European Gastroenterology Journal
Published
2025-12-05
DOI
https://doi.org/10.1002/ueg2.70141
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

Fiona D M van Schaik, Adriaan A. van Bodegraven, Mark Löwenberg, Bas Oldenburg et al.
United European Gastroenterology Journal
Inflammatory Bowel Disease
article

Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

Fiona D M van Schaik, Adriaan A. van Bodegraven, Mark Löwenberg, Bas Oldenburg, Nidhi Srivastava, Marieke J. Pierik, Zlatan Mujagic, Alexander Bodelier, Myrthe R Naber, Andrea E. van der Meulen‐de Jong, D G Bouwknegt, Marijn C. Visschedijk, Philip W. Voorneveld, Marjolijn Duijvestein, Rachel West, S. Veltkamp, L. M. M. Verleye
article en

Abstract

Filgotinib is an effective and well-tolerated treatment option for UC, including DTT disease. No new safety signals were found.

United European Gastroenterology JournalVol. 14(1)
Leiden University (NL), University Medical Center Groningen (NL), Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Radboud University Medical Center (NL), University Medical Center Utrecht (NL), Sint Franciscus Gasthuis (NL), Medisch Centrum Haaglanden (NL), Amphia Ziekenhuis (NL), Amsterdam Neuroscience (NL), Zuyderland Medisch Centrum (NL)
Openalex Percentile: Top 60%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.